Oguzcan Kinikoglu (Oğuzcan Kınıkoğlu)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 16

Top Topics

Tyrosine Kinase

Prognostic Factors

Ejection Fraction

Top Venues

Medicina (Kaunas, Lithuania)

Scientific reports

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Oguzcan Kinikoglu, Bala Başak Öven, Serkan Çelik, Nalan Alan Selçuk, Gamze Beydağı, Kaan Akçay, Levent Kabasakal
Investigating Combination Therapy: The Role of Lutetium-177 PSMA-617 Radioligand Therapy and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer. Journal of clinical medicine 13 (16) (2024)
Deniz Işık, Oguzcan Kinikoglu, Goncagul Akdag, Yunus Emre Altıntaş, Ezgi Türkoğlu, Sedat Yildirim, Heves Surmeli, Tuğba Başoğlu, Hatice Odabaş, Nedim Turan
Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-World Study. Medicina (Kaunas, Lithuania) 60 (7) (2024)
Oguzcan Kinikoglu, Hatice Odabaş, Yunus Emre Altıntaş, Anıl Yıldız, Burçin Çakan, Goncagül Akdağ, Sedat Yildirim, Hamit Bal, Tuğba Kaya, Salih Tünbekici, Deniz Işık, Tuğba Başoğlu, Mahmut Emre Yildirim, Nedim Turan
Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer. Medicina (Kaunas, Lithuania) 60 (6) (2024)
Deniz Işık, Oguzcan Kinikoglu, Goncagul Akdag, Yunus Emre Altıntaş, Ezgi Türkoğlu, Sedat Yildirim, Heves Surmeli, Tuğba Başoğlu, Hatice Odabaş, Nedim Turan
Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-World Study. Medicina (Kaunas, Lithuania) 60 (7) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Eyyüp Cavdar, Oguzcan Kinikoglu, Sila Oksuz, Hacer Sahika Yildiz, Aysun Kucukoz Uzun, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers 16 (14) (2024)
Oguzcan Kinikoglu, Hatice Odabaş, Yunus Emre Altıntaş, Anıl Yıldız, Burçin Çakan, Goncagül Akdağ, Sedat Yildirim, Hamit Bal, Tuğba Kaya, Salih Tünbekici, Deniz Işık, Tuğba Başoğlu, Mahmut Emre Yildirim, Nedim Turan
Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer. Medicina (Kaunas, Lithuania) 60 (6) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Eyyüp Cavdar, Oguzcan Kinikoglu, Sila Oksuz, Hacer Sahika Yildiz, Aysun Kucukoz Uzun, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers 16 (14) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal, Oguzcan Kinikoglu, Sila Oksuz, Ugur Ozkerim, Salih Tunbekici, Hacer Sahika Yildiz, Özkan Alan, Sermin Coban Kokten, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy. Scientific reports 14 (1) (2024)
Deniz Işık, Oguzcan Kinikoglu, Goncagul Akdag, Yunus Emre Altıntaş, Ezgi Türkoğlu, Sedat Yildirim, Heves Surmeli, Tuğba Başoğlu, Hatice Odabaş, Nedim Turan
Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-World Study. Medicina (Kaunas, Lithuania) 60 (7) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal, Oguzcan Kinikoglu, Sila Oksuz, Ugur Ozkerim, Salih Tunbekici, Hacer Sahika Yildiz, Özkan Alan, Sermin Coban Kokten, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy. Scientific reports 14 (1) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal, Oguzcan Kinikoglu, Sila Oksuz, Ugur Ozkerim, Salih Tunbekici, Hacer Sahika Yildiz, Özkan Alan, Sermin Coban Kokten, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy. Scientific reports 14 (1) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Eyyüp Cavdar, Oguzcan Kinikoglu, Sila Oksuz, Hacer Sahika Yildiz, Aysun Kucukoz Uzun, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers 16 (14) (2024)
Sedat Yildirim, Özkan Alan, Zeynep Yüksel Yasar, Tugba Kaya, Goncagul Akdag, Oguzcan Kinikoglu, Gonca Gul Gecmen, Alper Yaşar, Deniz Işık, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever, Mahmut Emre Yildirim, Hatice Odabaş, Nedim Turan
Prognostic Impact and Clinical Features of Spread through Air Spaces in Operated Lung Cancer: Real-World Analysis. Medicina (Kaunas, Lithuania) 60 (8) (2024)
Goncagul Akdag, Deniz Işık, Akif Dogan, Sedat Yildirim, Oguzcan Kinikoglu, Alper Topal, Sila Oksuz, Ezgi Turkoglu, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer? Medicina (Kaunas, Lithuania) 60 (8) (2024)
Oguzcan Kinikoglu, Bala Başak Öven, Serkan Çelik, Nalan Alan Selçuk, Gamze Beydağı, Kaan Akçay, Levent Kabasakal
Investigating Combination Therapy: The Role of Lutetium-177 PSMA-617 Radioligand Therapy and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer. Journal of clinical medicine 13 (16) (2024)
Goncagul Akdag, Özkan Alan, Akif Dogan, Zeynep Yüksel Yasar, Sedat Yildirim, Oguzcan Kinikoglu, Emre Kudu, Heves Surmeli, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience. World journal of urology (2023)